Bedingungsfaktoren psychopharmakologischer Behandlung bei leichter oder mittelgradiger Intelligenzminderung

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • M. Schützwohl - , Department of Psychiatry and Psychotherapy (Author)
  • E. Voss - , Heidelberg University  (Author)
  • M. Stiawa - , Ulm University (Author)
  • H. J. Salize - , Heidelberg University  (Author)
  • B. Puschner - , Ulm University (Author)
  • A. Koch - , Department of Psychiatry and Psychotherapy (Author)

Abstract

Background: During the past years the provision of mental healthcare for adults with intellectual disabilities (ID) has repeatedly been criticized; however, the number of relevant studies is still relatively few. Objective: The aim of the present study was to identify determinants for utilization of mental healthcare services and prescription of psychotropic medication in adults with mild to moderate ID. Material and methods: Analyses were based on data from 417 adults with mild to moderate ID, which had been collected within the cross-sectional MEMENTA study in three different regions of Germany. Logistic regression analyses were conducted to identify clinical and sociodemographic variables as predictors of utilization of mental healthcare services (n = 282) and psychotropic medication (n = 351). Results: Utilization of healthcare services and psychotropic medication were both associated with mental disorders and problem behavior. In addition, the likelihood of being treated with psychotropic medication and antipsychotic drugs was higher in adults living in residential homes. Conclusion: The findings indicate a lack of adherence to existing guidelines in the treatment of adults with ID living in residential homes.

Translated title of the contribution
Determinants of psychotropic medication in adults with mild or moderate intellectual disabilities

Details

Original languageGerman
Pages (from-to)1273-1280
Number of pages8
JournalNervenarzt
Volume88
Issue number11
Publication statusPublished - 1 Nov 2017
Peer-reviewedYes

External IDs

PubMed 27638741

Keywords

Sustainable Development Goals

Keywords

  • Health care utilization, Problem behavior, Psychotropic drugs